LRP1 and glioblastoma: Before confirming the feasibility of receptor-mediated delivery in vitro, the cellular cytotoxicity of RCD with and without oligomer, ligand–PEG, and PEG-modification was evaluated in human glioblastoma U87MG cells, which express LRP1 at a high level [46].